Drug intelligence / Profile preview

Yinshao Decoction

Development stage: Preclinical
Lead developer: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Yinshao Decoction is a Traditional Chinese Medicine (TCM) formula, administered in granule form, currently undergoing clinical investigation for the treatment of pediatric adenoid hypertrophy. In the context of TCM, it is specifically used to address the "Phlegm Coagulation and Blood Stasis Syndrome" associated with this condition.

Other names: 银芍汤Yinshao Decoction (in granule form)

Beyond the preview

Go deeper on Yinshao Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinshao Decoction.

Explore the full profile